ID

16455

Descrizione

Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00283608

collegamento

https://clinicaltrials.gov/show/NCT00283608

Keywords

  1. 17/07/16 17/07/16 -
Caricato su

17 luglio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT00283608

Eligibility Breast Cancer NCT00283608

Criteria
Descrizione

Criteria

diagnosis of breast cancer
Descrizione

Breast cancer

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678222
stage i, ii, or iii disease
Descrizione

Tumor stage

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1300072
resected disease
Descrizione

Resection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0728940
planning to undergo treatment with anastrozole at the clinically approved dose of 1 mg/day or mayo clinic cancer center rochester patient who will be enrolled on or has been enrolled on can-ncic-ma27 and has not started taking the study medication (anastrozole or exemestane)
Descrizione

Planned treatment with anastrozole

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3641097
UMLS CUI [1,2]
C0290883
hormone receptor status:
Descrizione

hormone receptor status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019929
estrogen receptor-positive and/or progesterone receptor-positive primary tumor
Descrizione

estrogen receptor-positive and/or progesterone receptor-positive primary tumor

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2919271
UMLS CUI [2]
C2919590
patient characteristics:
Descrizione

Patient characteristics

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0815172
female
Descrizione

Gender

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079399
postmenopausal
Descrizione

Menopausal status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0025320
able to complete questionnaires alone or with assistance
Descrizione

Questionnaire

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0034394
prior concurrent therapy:
Descrizione

Prior concurrent therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009429
more than 6 months since prior endocrine therapy, except tamoxifen
Descrizione

prior endocrine therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0279025
no other prior aromatase inhibitors (e.g., letrozole or exemestane)
Descrizione

Aromatase inhibitors

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0593802
no prior ovarian function suppression with surgery or radiotherapy, ovarian ablation, or luteinizing hormone-releasing hormone analogues (e.g., goserelin) as treatment for cancer
Descrizione

Ovarian suppression

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0677922

Similar models

Eligibility Breast Cancer NCT00283608

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Breast cancer
Item
diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
Tumor stage
Item
stage i, ii, or iii disease
boolean
C1300072 (UMLS CUI [1])
Resection
Item
resected disease
boolean
C0728940 (UMLS CUI [1])
Planned treatment with anastrozole
Item
planning to undergo treatment with anastrozole at the clinically approved dose of 1 mg/day or mayo clinic cancer center rochester patient who will be enrolled on or has been enrolled on can-ncic-ma27 and has not started taking the study medication (anastrozole or exemestane)
boolean
C3641097 (UMLS CUI [1,1])
C0290883 (UMLS CUI [1,2])
hormone receptor status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1])
estrogen receptor-positive and/or progesterone receptor-positive primary tumor
Item
estrogen receptor-positive and/or progesterone receptor-positive primary tumor
boolean
C2919271 (UMLS CUI [1])
C2919590 (UMLS CUI [2])
Patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Gender
Item
female
boolean
C0079399 (UMLS CUI [1])
Menopausal status
Item
postmenopausal
boolean
C0025320 (UMLS CUI [1])
Questionnaire
Item
able to complete questionnaires alone or with assistance
boolean
C0034394 (UMLS CUI [1])
Prior concurrent therapy
Item
prior concurrent therapy:
boolean
C0009429 (UMLS CUI [1])
prior endocrine therapy
Item
more than 6 months since prior endocrine therapy, except tamoxifen
boolean
C0279025 (UMLS CUI [1])
Aromatase inhibitors
Item
no other prior aromatase inhibitors (e.g., letrozole or exemestane)
boolean
C0593802 (UMLS CUI [1])
Ovarian suppression
Item
no prior ovarian function suppression with surgery or radiotherapy, ovarian ablation, or luteinizing hormone-releasing hormone analogues (e.g., goserelin) as treatment for cancer
boolean
C0677922 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial